Abstract:Background Targeted delivery of small interfering RNA (siRNA) has been regarded as one of the most important technologies for the development of siRNA therapeutics. However, the need for safe and efficient delivery systems is a barrier to further development of RNA interference therapeutics. In this work, a nontoxic and efficient siRNA carrier delivery system of low molecular weight polyethyleneimine (PEI-600 Da) cross-linked with 2-hydroxypopyl-β-cyclodextrin (HP-β-CD) and folic acid (FA) was synthesized for biomedical application. Methods The siRNA carrier was prepared using a simple method and characterized by nuclear magnetic resonance and Fourier transform infrared spectroscopy. The siRNA carrier nanoparticles were characterized in terms of morphology, size and zeta potential, stability, efficiency of delivery, and gene silencing efficiency in vitro and in vivo. Results The siRNA carrier was synthesized successfully. It showed good siRNA binding capacity and ability to protect siRNA. Further, the toxicity of the carrier measured in vitro and in vivo appeared to be negligible, probably because of degradation of the low molecular weight PEI and HP-β-CD in the cytosol. Flow cytometry and confocal microscopy confirmed that the FA receptor-mediated endocytosis of the FA-HP-β-CD-PEI/siRNA complexes was greater than that of the HP-β-CD-PEI/siRNA complexes in FA receptor-enriched HeLa cells. The FA-HP-β-CD-PEI/siRNA complexes also demonstrated excellent gene silencing efficiency in vitro (in the range of 90%), and reduced vascular endothelial growth factor (VEGF) protein expression in the presence of 20% serum. FA-HP-β-CD-PEI/siRNA complexes administered via tail vein injection resulted in marked inhibition of tumor growth and reduced VEGF protein expression in the tumors. Conclusion Our results suggest that the FA-HP-β-CD-PEI complex is a nontoxic and highly efficient gene carrier with the potential to deliver siRNA for cancer gene therapy effectively in vitro and in vivo.

Enhanced Sirna Delivery Using Oleic Acid Derivative of Polyethylenimine

Ε-Caprolactone-modified Polyethylenimine As Efficient Nanocarriers for Sirna Delivery in Vivo.

Bioreducible PEI-siRNA Nanocomplex for Liver Cancer Therapy: Transfection, Biodistribution, and Tumor Growth Inhibition in Vivo

Enhanced Hepatic Delivery of Sirna and Microrna Using Oleic Acid Based Lipid Nanoparticle Formulations

Alkane-modified low-molecular-weight polyethylenimine with enhanced gene silencing for siRNA delivery.

Guanidinated Thiourea-Decorated Polyethylenimines for Enhanced Membrane Penetration and Efficient siRNA Delivery.

Integration of Polylactide into Polyethylenimine Facilitates the Safe and Effective Intracellular siRNA Delivery

Systemic Delivery of Sirna with Cationic Lipid Assisted PEG-PLA Nanoparticles for Cancer Therapy.

N‐Alkyl‐PEI‐Functionalized Iron Oxide Nanoclusters for Efficient Sirna Delivery

A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.

Polylysine-modified Polyethylenimines As Sirna Carriers for Effective Tumor Treatment

Disassembly of Micelle-Like Polyethylenimine Nanocomplexes for Sirna Delivery: High Transfection Efficiency and Reduced Toxicity Achieved by Simple Reducible Lipid Modification.

A Polyethylenimine-Linoleic Acid Conjugate for Antisense Oligonucleotide Delivery

Copolymer of Poly(Ethylene Glycol) and Poly((L)-Lysine) Grafting Polyethylenimine Through A Reducible Disulfide Linkage for Sirna Delivery

Enhanced antisense oligonucleotide delivery using cationic liposomes incorporating fatty acid-modified polyethylenimine.

Efficient Systemic Delivery Of Sirna By Using High-Density Lipoprotein-Mimicking Peptide Lipid Nanoparticles

Mono-methoxy-poly(3-hydroxybutyrate-co-4-hydroxybutyrate)-graft-hyper-branched Polyethylenimine Copolymers for Sirna Delivery.

Gold Nanoparticles Capped with Polyethyleneimine for Enhanced Sirna Delivery

Low-weight Polyethylenimine Cross-Linked 2-Hydroxypopyl-β-cyclodextrin and Folic Acid As an Efficient and Nontoxic Sirna Carrier for Gene Silencing and Tumor Inhibition by VEGF Sirna

Porous Silicon Microparticles for Delivery of Sirna Therapeutics

Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems